A Retrospective Data Collection on NobelProcera® Zirconia Implant Bridges from 4 to 14 Units.

Nobel Biocare

Status: Active, not recruiting

Conditions: Dental Prosthesis, Implant-Supported

Treatments: Other: observational study, no intervention is required

Study type: Observational

Funder types: Industry

Identifiers

NCT06600451

2020-1690

Details and patient eligibility

About

This is a retrospective multicenter data collection in which clinical and radiographic data on implant zirconia bridges are collected from partially or fully edentulous subjects consecutively treated with at least one 4- to 14-unit NobelProcera® Zirconia Implant Bridge. This data collection will be conducted in up to 11 centers (see Appendix I) and will include between 150 to 200 subjects.

The aim of this retrospective multicenter data collection is to evaluate the safety, performance, and clinical benefits of NobelProcera® Zirconia Implant Bridges (4 to 14 units) in daily dental practice.

Enrollment: 200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Subject was at least 18 years old at the time of treatment,
• Subjects treated with at least one NobelProcera® Zirconia Implant Bridge (4- to 14-unit supported by 2 to 10 implants).

Exclusion criteria

• none

Trial design

200 participants in 1 patient group

Patients treated with NobelProcera Zr Implant Bridge (4-14-unit)

Description:

Patients partially and fully edentulous in need of the implant supported dental prosthesis treated with NobelProcera Zr Implant Bridge (4-14-unit) from June 2020. Device is CE and available on the market in May 2020.

Treatment:

Other: observational study, no intervention is required